Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 4;18(3):366.
doi: 10.3390/ph18030366.

Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract

Affiliations

Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract

Yoana Sotirova et al. Pharmaceuticals (Basel). .

Abstract

Background/Objectives: This study aims to gain insights into the antimicrobial and antiherpetic activity of hyperforin-rich Hypericum perforatum L. (HP) extract using nanostructured lipid carriers (NLCs) as delivery platforms. Methods: Two established NLC specimens, comprising glyceryl behenate and almond oil or borage oil, and their extract-loaded counterparts (HP-NLCs) were utilized. Their minimal bactericidal/fungicidal concentrations (MBC; MFC) were investigated against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 10145, Klebsiella pneumoniae ATCC 10031, and Candida albicans ATCC 10231. The anti-herpesvirus (HSV-1) potential was evaluated concerning antiviral and virucidal activity and impact on viral adsorption. Results: The borage oil-based extract-loaded nanodispersion (HP-NLC2) exhibited pronounced microbicidal activity against S. aureus (MBC 6.3 mg/mL), K. pneumoniae (MBC 97.7 µg/mL), and C. albicans (MFC < 48.8 µg/mL), unlike the almond oil-containing sample (HP-NLC1), which showed only weak inhibition of the fungal growth. HP-NLC2 was found to be less cytotoxic and to suppress HSV-1 replication slightly more than HP-NLC1, but generally, the effects were weak. Neither the empty lipid nanoparticles nor the HP extract-loaded carriers expressed activity against E. coli, P. aeruginosa, the HSV-1 extracellular virions, or viral adhesion. Conclusions: It could be concluded that both HP-NLC samples revealed only minor antiherpetic potential of the hyperforin-rich extract, but HP-NLC2 demonstrated significant antibacterial and antimycotic activity. Therefore, the latter was featured as a more convenient HP-carrier system for nano-designed dermal pharmaceutical formulations. Such a thorough investigation of hyperforin-determined anti-HSV-1 effects and antibacterial and antimycotic properties, being the first of its kind, contributes to the fundamental knowledge of HP and reveals new perspectives for the utilization, limitations, and therapeutic designation of its non-polar components.

Keywords: St. John’s wort; antibacterial activity; antifungal activity; antimicrobial activity; antiviral activity; herpesvirus; hyperforin; lipid nanoparticles; nanostructured lipid carriers; phloroglucinols.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Chemical structures of the main phloroglucinols (A) and naphthodianthrones (B) present in Hypericum perforatum L.
Figure 2
Figure 2
Physicochemical characteristics of “blank” and hyperforin-rich HP extract-loaded lipid nanoparticles. Subfigure (A) presents the visual appearance of the obtained lipid nanodispersions. The extract-loaded ones were stored in amber glass vials but were photographed in transparent ones to display their qualitative characteristics. Mean particle size (Z-average), polydispersity index, zeta potential (B), and entrapment efficiency (C) of the nanoparticles were assessed immediately after their preparation and after 30-day storage at 4 °C. Subfigure (D) demonstrates the shape and inner morphology of the nanocarriers. Data from the study of Sotirova et al. [32] were used for constructing the figure.
Figure 3
Figure 3
Antibacterial and antifungal activity of the “blank” NLC samples.
Figure 4
Figure 4
Antibacterial and antifungal activity of the HP-NLC samples.

References

    1. Galeotti N. Hypericum perforatum (St John’s wort) beyond depression: A therapeutic perspective for pain conditions. J. Ethnopharmacol. 2017;200:136–146. doi: 10.1016/j.jep.2017.02.016. - DOI - PubMed
    1. Ersoy E., Özkan E.E. Hypericum perforatum (St John’s Wort) for Depression Treatment from Past to Present-What Do We Know? J. Lit. Pharm. Sci. J. 2020;9:137–148. doi: 10.5336/pharmsci.2019-72764. - DOI
    1. Zhang R., Ji Y., Zhang X., Kennelly E.J., Long C. Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology. J. Ethnopharmacol. 2020;254:112686. doi: 10.1016/j.jep.2020.112686. - DOI - PubMed
    1. Estrada M., Chávez-Nomberto R.E., Tsuneto A.P., Crestani A.S., Awad C., Takahiro Chone C., Kimura D., Quiroz Robladillo D., de Azevedo Lopes E., Ibrahim Abdullah H., et al. Anti-inflammatory Effects of Topical Hypericum perforatum: A Systematic Review. Princ. Pract. Clin. Res. J. 2023;9:47–52. doi: 10.21801/ppcrj.2023.91.8. - DOI
    1. Wölfle U., Seelinger G., Schempp C.M. Topical application of St. John’s wort (Hypericum perforatum) Planta Med. 2014;80:109–120. - PubMed

LinkOut - more resources